Ginsenosides on Cancer and Related Clinical Studies
Ginsenosides on Cancer and Related Clinical Studies
Cancer is a leading cause of death globally, and its treatment often involves a combination of surgery, chemotherapy, and radiation therapy. These treatments, however, are not always effective, particularly in advanced stages of the disease, and can have significant side effects. Therefore, there is a need for alternative therapies that can improve the effectiveness of cancer treatment while minimizing side effects.
Ginsenosides are a group of steroidal saponins (as shown in figure 1) that are primarily found in the root of the Panax ginseng plant. These compounds have been widely used in traditional Chinese medicine for their various health benefits, including anti-inflammatory, anti-oxidative, and anti-cancer properties. In recent years, there has been a growing interest in the potential of ginsenosides as anti-cancer agents.
Figure 1: Ginsenosides Group
Mechanism of Action of Ginsenosides on Cancer
Several studies have demonstrated the anti-cancer properties of ginsenosides. Ginsenosides can inhibit the growth and proliferation of cancer cells in vitro and in vivo. Ginsenosides can induce apoptosis (programmed cell death) in cancer cells, prevent tumor angiogenesis (the formation of new blood vessels to supply the tumor with nutrients and oxygen), and inhibit the invasion and metastasis (spread) of cancer cells.
One of the most studied ginsenosides for its anti-cancer properties is ginsenoside Rg3. A study published in the Journal of Ginseng Research showed that ginsenoside Rg3 inhibited the growth and invasion of prostate cancer cells in vitro and in vivo. Another study published in the same journal showed that ginsenoside Rg3 could enhance the anti-cancer effects of cisplatin, a commonly used chemotherapy drug, in lung cancer cells.
In addition, ginsenoside Rg3 has been studied for its potential to reduce the side effects of chemotherapy and radiation therapy. A study published in the Journal of Radiation Research showed that ginsenoside Rg3 could reduce the damage to healthy cells caused by radiation therapy in mice. Another study published in the Journal of Ethnopharmacology showed that ginsenoside Rg3 could reduce the toxicity of cisplatin in mice.
Ginsenosides have also been found to have anti-cancer effects in other types of cancer, including breast cancer, liver cancer, and colorectal cancer. In a study published in the Journal of Agricultural and Food Chemistry, ginsenosides were found to inhibit the growth of breast cancer cells in vitro and in vivo. Another study published in the same journal showed that ginsenosides could inhibit the growth and invasion of liver cancer cells.
Ginsenosides have also been found to have immunomodulatory effects. The immune system plays a crucial role in cancer development and progression. A study published in the International Journal of Molecular Sciences showed that ginsenosides could enhance the activity of natural killer (NK) cells, which are part of the innate immune system and play a key role in the destruction of cancer cells.
Challenges Associated with the Use of Ginsenosides as Anti-cancer Agents
Despite the promising results, there are some challenges associated with the use of ginsenosides as anti-cancer agents. One of the main challenges is the variability in the quality and composition of ginseng extracts, which can affect the bioavailability and effectiveness of ginsenosides. In addition, the optimal dose and route of administration of ginsenosides for cancer treatment are still unclear, and more research is needed to determine their safety and potential side effects.
Despite the promising results from preclinical studies, there are limited clinical studies on the anti-cancer properties of ginsenosides. One of the main challenges in the clinical use of ginsenosides is their poor bioavailability, which can limit their therapeutic efficacy. However, several clinical studies have shown that ginsenosides can improve the quality of life of cancer patients by reducing the side effects of chemotherapy and radiation therapy.(as shown in figure 2)
Figure 2:Clinical studies reference
For instance, a clinical study of ginsenoside Rg3 in combination with chemotherapy in patients with non-small cell lung cancer showed a significant improvement in overall survival and progression-free survival compared to chemotherapy alone. Similarly, a clinical study of ginseng extract in breast cancer patients undergoing chemotherapy showed a reduction in fatigue and improvement in quality of life.
Ginsenosides have emerged as promising anti-cancer agents that can inhibit the growth and proliferation of cancer cells, induce apoptosis, prevent tumor angiogenesis, and inhibit the invasion and metastasis of cancer cells. Ginsenoside Rg3, in particular, has been extensively studied for its anti-cancer properties and potential to reduce the side effects of chemotherapy and radiation therapy. However, more research is needed to determine the optimal dose, route of administration, and safety profile of ginsenosides in humans. With further research, ginsenosides could potentially become a valuable addition to the current arsenal of cancer treatments, offering new hope to patients with cancer.
1. Liu J, et al. Ginsenoside Rg3 Inhibits Prostate Cancer Cells Proliferation by Decreasing Expression of Cox-2, Survivin and PCNA. International Journal of Clinical and Experimental Medicine. 2014;7(5):1054-60.
2. Wang CZ, et al. Panaxadiol and panaxatriol are effective chemopreventive agents against lung cancer. Planta Med. 2012 Mar;78(4):340-6.
3. Li X, et al. Ginsenoside Rg3 enhances the sensitivity of human NSCLC cells to platinum drugs through the inhibition of CXCR4. Cell Physiol Biochem. 2015;36(2):685-96.
4. Yang J, et al. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and reversing EMT. Biomed Pharmacother. 2019 Feb;110:227-239.
5. Gao JL, et al. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on pancreatic cancer cells. Mol Med Rep. 2017 Apr;15(4):2057-2064.
6. Lu J, et al. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia-inducible factor 1α. Tumour Biol. 2016 Jul;37(7):9649-58.
7. Zhang X, et al. Ginsenoside Rg3 enhances the radiosensitivity of human oral squamous cell carcinoma cells. Am J Transl Res. 2019 May 15;11(5):2764-2774.
8. Yun TK. Experimental and epidemiological evidence of cancer preventive potential of Panax ginseng C.A. Meyer. Nutr Cancer. 2000;37(1):1-12.
9. Park HJ, et al. Anti-cancer activities of ginsenoside Rg3 against hepatocellular carcinoma: A review. Crit Rev Food Sci Nutr. 2018;58(8):1367-1373.
10. Liu J, et al. Ginsenoside Rg3 enhances natural killer cell activity against hepatocellular carcinoma cells by regulating the expression of NKG2D and CD16. Exp Ther Med. 2019 Jan;17(1):273-278.